Concepedia

Jue Zeng

JZ

Statistics

Publications

13

Citations

1.9K

H-Index

13

Active since

2004

Affiliations

University of California, Irvine(Current)

Novartis (China)

Novartis (United States)

Washington University in St. Louis

National Human Genome Research Institute

Jue Zeng is an author at University of California, Irvine specializing in molecular oncology, life sciences, and molecular biology.

Publications per year

2004–2022

13

Publications

13

Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation

Wei Qi, Homan Chan, Lin Teng et al. · Proceedings of the National Academy of Sciences · 2012 · 545 citations · Full text

, , +17

Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53

Ting Wang, Jue Zeng, Craig B. Lowe et al. · Proceedings of the National Academy of Sciences · 2007 · 405 citations · Full text

, , +10

An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED

Wei Qi, Kehao Zhao, Justin Gu et al. · Nature Chemical Biology · 2017 · 321 citations · Full text

, , +7

Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers

Lawrence Dearth, Qian Hua, Ting Wang et al. · Carcinogenesis · 2006 · 141 citations

, , +12

Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy

Ying Huang, Jeff Zhang, Zhengtian Yu et al. · Journal of Medicinal Chemistry · 2017 · 103 citations · Full text

, , +17

1–5 of 13